Annual report pursuant to Section 13 and 15(d)

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY

v3.24.1.1.u2
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Beginning balance, value at Mar. 31, 2022 $ 2 $ 197,370 $ (184,363) $ (4,312) $ 8,697
Beginning balance, shares at Mar. 31, 2022 3,100,937        
Proceeds from the At-the-Market sale of common stock, net of offering expenses $ 3 2,865 2,868
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 1,819,593        
Employee stock-based compensation expenses 649 649
Stock based compensation related to issuance of common stock restricted stock grants 20 20
Stock based compensation related to issuance of common stock restricted stock grants, shares 13,020        
Foreign currency translation adjustment 894 894
Net loss (5,151) (5,151)
Ending balance, value at Mar. 31, 2023 $ 5 200,904 (189,514) (3,418) 7,977
Ending balance, shares at Mar. 31, 2023 4,933,550        
Adjustment to correct par value $ (4) 4
Proceeds from the sale of common stock, net of offering expenses $ 1 1,445 1,446
Proceeds from the sale of common stock, net of offering expenses, shares 8,500,000        
Proceeds from the At-the-Market sale of common stock, net of offering expenses 338 338
Proceeds from the At-the-Market sale of common stock, net of offering expenses, shares 1,923,100        
Employee stock-based compensation expenses 255 255
Stock based compensation related to issuance of common stock restricted stock grants 261 261
Stock based compensation related to issuance of common stock restricted stock grants, shares 250,783        
Foreign currency translation adjustment 695 695
Net loss (4,835) (4,835)
Ending balance, value at Mar. 31, 2024 $ 2 $ 203,207 $ (194,349) $ (2,723) $ 6,137
Ending balance, shares at Mar. 31, 2024 15,607,433